3913-23-3 Usage
Description
2-Methoxy-5-nitrobenzyl bromide is an organic compound that serves as a potential mechanism-based inactivator of enzymes involved in O-dealkylations. It is characterized by its ability to modify tryptophan residues and is utilized in various applications across different industries.
Uses
Used in Pharmaceutical Industry:
2-Methoxy-5-nitrobenzyl bromide is used as a modifying agent for enhancing the activity of tryptophan residues in mouse interferon. This modification improves the effectiveness of the interferon, which plays a crucial role in the immune response against various diseases and conditions.
Used in Chemical Synthesis:
2-Methoxy-5-nitrobenzyl bromide is used as a reagent for sulfhydryl modification, which is an essential process in the synthesis of certain chemicals and compounds. Its ability to modify sulfhydryl groups makes it a valuable tool in the development of new chemical entities and pharmaceuticals.
Biochem/physiol Actions
2-Methoxy-5-nitrobenzyl bromide inactivates cytochrome P-450 in male rat liver microsomes.
Check Digit Verification of cas no
The CAS Registry Mumber 3913-23-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,9,1 and 3 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 3913-23:
(6*3)+(5*9)+(4*1)+(3*3)+(2*2)+(1*3)=83
83 % 10 = 3
So 3913-23-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H8BrNO3/c1-13-8-3-2-7(10(11)12)4-6(8)5-9/h2-4H,5H2,1H3
3913-23-3Relevant articles and documents
THERAPEUTIC COMPOUNDS
-
Paragraph 0395; 0403; 0407, (2017/01/23)
The invention provides compounds of formula (I): wherein, A, C, D, X, and Y have any of the values defined in the specification, and salts thereof. The compounds are SIRT2 inhibitors and are useful for treating SIRT2 associated conditions.
COMPOUNDS THAT MODULATE EGFR ACTIVITY AND METHODS FOR TREATING OR PREVENTING CONDITIONS THEREWITH
-
Page/Page column 56-57, (2011/11/30)
Provided are compounds and methods for treating or preventing kinase-mediated disorders therewith.
COMPOUNDS
-
, (2008/06/13)
This invention relates to novel carboxylic acid indole compounds and compositions for use in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8).